Serotype Iii Gbs
Serotype Iii Gbs - Related Videos
09:11
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
0 Views •
Cited by 32 •
2014
Latex agglutination testing is a simple, rapid and inexpensive method for serotyping Streptococcus pneumoniae, and has also been widely applied in diagnostic microbiology. This manuscript describes the in-house production of latex agglutination reagents, quality control procedures and the application of this technique to pneumococcal serotyping.
04:25
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
0 Views •
Cited by 86 •
2014
The Quellung reaction is the gold standard technique for serotyping Streptococcus pneumoniae. This technique utilizes a microscope and specific pneumococcal antisera and is commonly used in reference and research laboratories worldwide.
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
0 Views •
Cited by 1 •
2015
Here, we present a protocol to generate a proof-of-principle divalent adenovirus type 5 (Ad5) vector Ad5/H5-HVR1-KWAS-HVR5-His6 by utilizing the Antigen Capsid-Incorporation strategy. This vector was demonstrated to exhibit qualitative fitness, the capability to escape Ad5-positive sera in vitro, and the antigenicity as well as immunogenicity to the incorporated antigens.
06:50
Synthesis Of A Ti(III) Metallocene Using Schlenk Line Technique
0 Views •
2023
Source: Tamara M. Powers, Department of Chemistry, Texas A&M University Inorganic chemists often work with highly air- and water-sensitive compounds. The two most common and practical methods for air-free synthesis utilize either Schlenk lines or gloveboxes. This experiment will demonstrate how to perform simple manipulations on a Schlenk line with a focus on solvent preparation and transfer. Through the synthesis of a reactive Ti(III) metallocene complex, we will demonstrate a new, simple...
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
0 Views •
Cited by 9 •
2018
Here we describe the delivery of microRNA using a recombinant adeno-associated virus serotype 9 in a mouse model of a neuromuscular disease. A single peripheral administration in mice resulted in sustained miRNA overexpression in muscle and motor neurons, providing an opportunity to study miRNA function and therapeutic potential in vivo.
FAQs
Its polysaccharide capsule contains sialic acid residues that help reduce complement-mediated opsonization and phagocytic clearance. By limiting these immune processes, the capsule can support bacterial persistence after transmission and create conditions that favor invasion. This capsule-host interaction is therefore central to understanding why serotype-specific features matter in studies of invasive GBS infection.
Sialic acid residues are a notable component of the serotype III GBS capsule because they contribute to interactions with host immune defenses. Their presence is linked to reduced complement-mediated opsonization and less efficient phagocytic clearance. Examining these residues helps researchers connect capsule structure with persistence, invasion, and the development of immune-based prevention strategies.
When the capsule helps GBS resist complement-mediated opsonization and phagocytic clearance, the organism may persist rather than being removed promptly by host defenses. Persistence can support subsequent invasion after transmission, including transmission during childbirth. This mechanism provides immunological context for the strong clinical association between serotype III GBS and severe neonatal disease.
The association reflects the importance of both transmission timing and capsule-mediated immune evasion. During childbirth, transmission can place the organism in contact with a newborn, while the serotype III capsule supports persistence and invasion by resisting key clearance mechanisms. These combined factors help explain its significance in investigations of neonatal sepsis and meningitis.
Accurate identification supports surveillance, risk assessment, and prevention planning. It allows investigators and healthcare programs to recognize the clinically important serotype III pattern rather than treating all GBS observations as interchangeable. The resulting information can contribute to maternal screening strategies, antibiotic prophylaxis decisions, and broader monitoring of invasive disease.
Research on serotype III GBS connects capsule biology and transmission during childbirth with practical prevention measures. Identifying this clinically important variant can support risk assessment and surveillance, while maternal screening and antibiotic prophylaxis address prevention around childbirth. Together, these approaches aim to reduce the likelihood that transmission will progress to invasive neonatal infection.
The serotype-specific polysaccharide capsule provides a defined focus for vaccine research. Studying its structure, including sialic acid residues, and its interactions with host immune defenses can guide efforts to develop prevention strategies that address persistence and invasion. This work complements maternal screening and antibiotic prophylaxis by exploring immunological protection against invasive GBS disease.
These studies can clarify how complement-mediated opsonization, phagocytic clearance, and capsule structure interact during infection. They also connect laboratory investigation with clinical outcomes such as neonatal sepsis, meningitis, and invasive disease in adults. Such findings help define which host defense processes are relevant to risk assessment, prevention research, and the interpretation of serotype-specific disease patterns.